Monday, June 17, 2013

Fwd: qotd: Replace volume with quality?

_______________________________________________
Quote-of-the-day mailing list
Quote-of-the-day@mccanne.org
http://two.pairlist.net/mailman/listinfo/quote-of-the-day

-------- Original Message --------
Subject: qotd: Replace volume with quality?
Date: Mon, 17 Jun 2013 10:44:00 -0700
From: Don McCanne <don@mccanne.org>
To: Quote-of-the-Day <quote-of-the-day@mccanne.org>



The Wall Street Journal
June 16, 2013
Should Physician Pay Be Tied to Performance?
No: The System Is Too Easy to Game—and Too Hard to Set Up
By Steffie Woolhandler

Paying doctors for better care—not just more of it—seems like a
no-brainer. Yet rigorous studies of pay-for-performance bonuses have
found no health benefits and some unintended harms.

An exhaustive analysis of pay-for-performance research by the Cochrane
Collaborative, an international group that reviews medical evidence,
unearthed "no evidence that financial incentives can improve patient
outcomes."

Consider these cases. In Britain's massive pay-for-performance program,
family doctors earned almost perfect scores (and big bonuses) for
hypertension treatment, but population surveys found no decrease in
blood pressure or its main complication, strokes. Meanwhile, aspects of
quality that didn't bring bonuses deteriorated.

The largest U.S. pay-for-performance experiment—Medicare's Premier
Demonstration—also flopped. The 200 hospitals that offered bonuses
scored slightly worse on patient death rates than other hospitals.

Proponents argue that programs like these were flawed in one way or
another, and that the next trial—or the one after—will certainly do
better. They also claim successes with other programs. But none of these
claims rest on rigorous science, and all those that have subsequently
been subjected to rigorous tests have failed.

No Easy Measurement

Why do these programs consistently fall short? Measurement is distorted
once you pay doctors based on the data they themselves create. High
scores may reflect real excellence, but can just as easily reflect
cherry-picking or gaming the measurement system.

One Boston-area hospital we observed improved its quality score 40% just
by getting doctors to change the words they wrote in patients' charts.
Medicare gives hospitals more credit for saving patients with "acute
respiratory decompensation" than those with "COPD exacerbations,"
although these terms are synonyms. That kind of practice is neither
illegal nor unusual.

Beyond that, it's devilishly difficult to quantify doctors' performance
in the first place. Hospital death rates seem, at first glance, an ideal
measure of medical quality. Yet, four widely used algorithms yield
completely different mortality rankings; a hospital rated outstanding in
one often looks downright dangerous in another.

Even if—as some proponents argue—we find performance measures that work
for one group of doctors, it's unlikely that they'll work for all
providers in all patient populations. Moreover, many providers interact
in providing care, and influence each other and patients' outcomes in
complex ways. It's hard to imagine that incentives could optimize this
as a system.

Ignoring Psychology

There's also psychology at work. Rewarding performance ignores the
complexity of human drive, particularly the role of intrinsic
motivation—the desire to perform an activity for its own inherent
rewards. Offering your dinner-party host a $10 reward for cooking a
wonderful meal isn't likely to motivate future invitations.

Studies have found that financial incentives often crowd out intrinsic
motivation. For instance, college students will spontaneously play with
interesting puzzles, but once they're paid to solve them, they lose
interest in playing for nothing. When day-care centers in Israel imposed
fines on parents for picking up children late, tardiness increased.
Promptness transformed from a moral duty to a market transaction.

Pay for performance undermines the mindset required for good
doctoring—the drive to do good work even when no one is looking.
Moreover, it forces doctors to shift their attention from patients to
computer screens—documenting trivial details useless for patient care
but essential for compliance.

None can doubt medicine's grave quality problems. As a remedy, pay for
performance suggests manipulating greed. This can certainly change
medicine, but not necessarily in the ways that we would plan, much less
hope for.

(Dr. Woolhandler is a physician and professor at the City University of
New York School of Public Health. David U. Himmelstein, also a physician
and professor at the School of Public Health, and Dan Ariely, the James
B. Duke professor of behavioral economics at Duke University's Fuqua
School of Business, contributed to this article.)

http://online.wsj.com/article/SB10001424127887323528404578454432476458370.html


Comment: We keep hearing over and over that we are going to have to
quit paying physicians based on the volume of their services and pay on
the quality of those services instead. There are two problems with this.

The first problem is that there is a certain volume of health care that
needs to be delivered. If the physician is told that quality counts but
volume doesn't, then wouldn't that physician be motivated to cut back on
work done? Does anyone seriously suggest that sloth is fine - payment
would be the same regardless of the volume of work? Of course not.
Whether fee-for-service or salaried, the physician is going to have to
produce.

The second problem is that the abstract concept that physician pay
should be tied to quality does not translate into a practical model of
measuring and rewarding quality. Physicians already attempt to provide
the best quality they can under the given clinical circumstances.
Typical measures selected are only a infinitesimal sampling of the
entire work product of the physician. Today's article explains the
deficiencies of trying to come to any conclusion about quality based on
this process.

The counter opinion to the article above was written by François de
Brantes, executive director of the Health Care Incentives Improvement
Institute, and is available at the same link above. Some of his comments
are instructive: "show poor outcomes in some pay-for-performance
trials," "design flaws," "doctors were rewarded for results that were
actually poor," "it has worked, if not always as well as it should,"
and, "problems can be fixed by not letting providers set benchmarks." If
physicians, with their conflicts of interest, don't define quality, then
who does? The MBAs? Is that really better?

We definitely must address medicine's many quality problems, ideally
through beneficent public policies, but manipulating greed through pay
for performance schemes is not the way to get there.

Friday, June 14, 2013

Fwd: qotd: Would Syria benefit from a single payer system?

_______________________________________________
Quote-of-the-day mailing list
Quote-of-the-day@mccanne.org
http://two.pairlist.net/mailman/listinfo/quote-of-the-day

-------- Original Message --------
Subject: qotd: Would Syria benefit from a single payer system?
Date: Fri, 14 Jun 2013 10:35:49 -0700
From: Don McCanne <don@mccanne.org>
To: Quote-of-the-Day <quote-of-the-day@mccanne.org>



MEDECINS SANS FRONTIERES
May 23, 2013
Syria: An overview of MSF programmes in and around the country

The conflict in Syria is extremely intense. Frontlines continue to
shift. The medical system is reduced to tatters. An estimated 6.8
million people are in urgent need of humanitarian assistance inside
Syria and in the neighbouring countries. And people in enclaves are cut
off from assistance.

Despite the very real challenges of operating in the country, MSF is now
running five hospitals inside Syria and is increasing mobile clinic
activities around some of these hospitals. Simultaneously, MSF is
actively seeking to open new projects where it is safe to do so.

MSF is using only private donations for its work in Syria in order to
remain entirely independent of all political positioning around the crisis.

MSF is also working in the neighbouring countries: Iraq, Jordan, Lebanon
and Turkey where some 1.5 million Syrians have fled. These countries
have been overwhelmed by the influx of refugees and the humanitarian
response has so far been unable to meet their needs.

http://www.msf.org/article/syria-overview-msf-programmes-and-around-country

And...

The New York Times
June 13, 2013
U.S. Is Said to Plan to Send Weapons to Syrian Rebels
By Mark Mazzetti, Michael R. Gordon and Mark Landler

The Obama administration, concluding that the troops of President Bashar
al-Assad of Syria have used chemical weapons against rebel forces in his
country's civil war, has decided to begin supplying the rebels for the
first time with small arms and ammunition, according to American officials.

Supplying weapons to the rebels has been a long-sought goal of advocates
of a more aggressive American response to the Syrian civil war.

But even with the decision to supply lethal aid, the Obama
administration remains deeply divided about whether to take more
forceful action to try to quell the fighting, which has killed more than
90,000 people over more than two years.

http://www.nytimes.com/2013/06/14/world/middleeast/syria-chemical-weapons.html

New York Times Reader Comment:

Don McCanne
San Juan Capistrano, CA

They have a tragic conflagration over there and we're helping by pouring
more gasoline on it?

Is "Peace on Earth" only for Christmas cards?

http://www.nytimes.com/2013/06/14/world/middleeast/syria-chemical-weapons.html?comments#permid=425


Comment: Syria needs their Mahatma Gandhi - someone who will be an
inspiration for non-violence and civil rights.

And single payer for Syria? We can't even get single payer in the United
States. Perhaps we need our own Mahatma Gandhi.

Wednesday, June 12, 2013

Fwd: qotd: Are physicians driven by profits or fear?

_______________________________________________
Quote-of-the-day mailing list
Quote-of-the-day@mccanne.org
http://two.pairlist.net/mailman/listinfo/quote-of-the-day

-------- Original Message --------
Subject: qotd: Are physicians driven by profits or fear?
Date: Wed, 12 Jun 2013 12:04:37 -0700
From: Don McCanne <don@mccanne.org>
To: Quote-of-the-Day <quote-of-the-day@mccanne.org>



JAMA Internal Medicine
June 10, 2013
Appropriate Use of Myocardial Perfusion Imaging in a Veteran Population
Profit Motives and Professional Liability Concerns
By David E. Winchester, MD, MS; Ryan Meral, BA; Scott Ryals, MD; Rebecca
J. Beyth, MD, MSc; Leslee J. Shaw, PhD

Myocardial perfusion imaging (MPI) is performed millions of times
annually in the United States to assess patients for coronary ischemia.
Some have expressed concern that MPI is being used inappropriately,
possibly because of self-referral profit motives and professional
liability fears. To inform clinicians about situations in which patients
are likely to benefit from MPI testing, appropriate use criteria (AUCs)
for MPI were developed, last revised in 2009. Prior investigations have
applied AUCs to describe the magnitude and patterns of inappropriate
testing. Rates of inappropriate testing have ranged from 7% to 24%. We
hypothesized that the single-payer environment of the Veterans Affairs
(VA) health system, which eliminates self-referral profit motive and
limits liability concern, will result in less inappropriate use of MPI.

Results

For all but 4 patients (1%), an indication from the 2009 AUCs could be
identified. Study indications were 78% (n = 259) appropriate, 13% (n =
42) inappropriate, and 8% (n = 27) uncertain. The most common
inappropriate MPI indications included testing of patients with low
pretest probability who could have undergone treadmill electrocardiogram
testing (7 patients [16.7% of total inappropriate MPI]) and asymptomatic
patients with low coronary heart disease risk (7 patients [16.7% of
total inappropriate MPI]).

Discussion

In this retrospective cross-sectional investigation regarding the
appropriate use of MPI in a VA health care setting, we observed that a
substantial portion of MPI tests were ordered for inappropriate
indications. The findings are in contrast to our initial hypothesis but
are similar to those of another VA-based investigation, the results of
which were published during our investigation.

Our hypothesis was based on unique characteristics of the VA patient
care environment. First, no self-referral or profit motives exist.
Second, whereas the Federal Tort Claims Act permits medical malpractice
lawsuits against federally employed physicians, the substantial majority
of claims are resolved through administrative processes.

We did not detect a significant reduction in inappropriate testing in
the VA environment, which suggests a lesser role of defensive medicine
and self-referral in the inappropriate use of MPI.

Reasons for the observed patterns of ordering MPI are unclear.
Conceivably, commonalities in medical training, independent of
postgraduate practice environment, could contribute to an exaggerated
perception of benefit of MPI in asymptomatic patients and those at low
risk of coronary heart disease.

http://archinte.jamanetwork.com/article.aspx?articleid=1696189


Comment: This study has two important lessons for health reform
advocates - one obvious and the other not so obvious.

The obvious lesson is that "excessive" medical interventions occur even
in the absence of greed or fear. In this study, since VA physicians
receive no additional income with an increased volume of services - in
this case the ordering of myocardial perfusion imaging - the tests that
were inappropriate were not done to increase personal income. Also,
since most VA malpractice claims are resolved administratively, there is
a much lower fear factor that would cause physicians to order tests to
reduce the risk of liability lawsuits.

This is good news in the respect that we can dismiss any nefarious
motives on the part of most physicians who are recommending
interventions that seem to be excessive. Policy corrections should be
directed instead to the more important causes of excessive medical
interventions.

This leads to the more subtle lesson of this study. What retrospectively
is considered to be inappropriate medical management was done by
physicians who, at the time, thought that they were doing the right
thing for the patient. The policy recommendation that should follow is
that we should continue to identify best practices and continue to
educate our health professionals on just what those best practices are.

We are already doing this in the form of medical research and continuing
medical education. The process can be enhanced by greater reliance on
organizations such NICE, Cochrane, and several others. If we want to
reduce unnecessary care, our resources should be directed to these
efforts rather than being wasted on administrative excesses such as
accountable care organizations that rely on feeble measurements that are
used to distribute nominal rewards and punishments - not really much of
a motivator but more of an insult for dedicated physicians.

Physicians appreciate receiving good information and will use that in
their practices. Let's make better use our public agencies, such as the
NIH, that are dedicated to the health of patients, rather than private
agencies that jerk our health care dollars around to conform to their
business models.

Single payer really would shift the motive from "money first" to
"patients and their health first."